These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2248731)

  • 21. Differential localization of dopamine D1 and D2 receptors in rat retina.
    Tran VT; Dickman M
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1620-6. PubMed ID: 1532792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of binding of 3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions.
    Hyttel J; Arnt J
    J Neural Transm; 1987; 68(3-4):171-89. PubMed ID: 2881976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study.
    Rao PA; Molinoff PB; Joyce JN
    Brain Res Dev Brain Res; 1991 Jun; 60(2):161-77. PubMed ID: 1832594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localization of nigrostriatal dopamine receptor subtypes and adenylate cyclase.
    Filloux F; Dawson TM; Wamsley JK
    Brain Res Bull; 1988 Apr; 20(4):447-59. PubMed ID: 3135077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O; Mohringe B; Fowler CJ
    J Neural Transm; 1987; 69(3-4):163-77. PubMed ID: 2957465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative autoradiographical analysis of the age-related modulation of central dopamine D1 and D2 receptors.
    Morelli M; Mennini T; Cagnotto A; Toffano G; Di Chiara G
    Neuroscience; 1990; 36(2):403-10. PubMed ID: 2215930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
    Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E
    Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brain D1 dopamine receptor in alloxan-induced diabetes.
    Salković M; Lacković Z
    Diabetes; 1992 Sep; 41(9):1119-21. PubMed ID: 1386820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rat dopaminergic function in the retina during aging.
    Riccardi F; Covelli V; Spano PF; Govoni S; Trabucchi M
    Neurobiol Aging; 1981; 2(3):229-31. PubMed ID: 6273758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.
    Savasta M; Dubois A; Benavides J; Scatton B
    Neurosci Lett; 1986 Dec; 72(3):265-71. PubMed ID: 2950341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: distribution, regulation and relationship to coupling.
    Hervé D; Trovero F; Blanc G; Glowinski J; Tassin JP
    Neuroscience; 1992; 46(3):687-700. PubMed ID: 1532052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum.
    Andersen PH; Grønvald FC; Jansen JA
    Life Sci; 1985 Nov; 37(21):1971-83. PubMed ID: 2415793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topography of substantia nigra innervation by D1 receptor-containing striatal neurons.
    Altar CA; Hauser K
    Brain Res; 1987 Apr; 410(1):1-11. PubMed ID: 2953407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W; Ruperto V; Crosby G; Iorio LC; Barnett A
    Life Sci; 1984 Oct; 35(18):1885-93. PubMed ID: 6387355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The renal dopaminergic system in ageing.
    Ricci A
    J Auton Pharmacol; 1990; 10 Suppl 1():s19-24. PubMed ID: 2151517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G; Kula NS; Baldessarini RJ
    Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic treatment with antidepressants decreases the number of [3H]SCH 23390 binding sites in the rat striatum and limbic system.
    Klimek V; Nielsen M
    Eur J Pharmacol; 1987 Jul; 139(2):163-9. PubMed ID: 3308491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
    Gredal O; Nielsen M; Hyttel J
    Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.